Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Symptomatic relief from at-home use of activated Bifidobacterium infantis EVC001 probiotic in infants: results from a consumer survey on the effects on diaper rash, colic symptoms, and sleep
in Beneficial MicrobesSearch for other papers by S.M. Dimitratos in
Current site
Google Scholar
Search for other papers by H. Brown in
Current site
Google Scholar
Search for other papers by T. Shafizadeh in
Current site
Google Scholar
Search for other papers by S. Kazi in
Current site
Google Scholar
Calabasas Pediatrics Wellness Center, Calabasas, CA 91302, USA.
Search for other papers by T. Altmann in
Current site
Google Scholar
Search for other papers by B. Ostrer in
Current site
Google Scholar
The gut microbiome during infancy is directly involved in the digestion of human milk, development of the immune system, and long-term health outcomes. Gut dysbiosis in early life has been linked to multiple short-term ailments, from diaper dermatitis and poor stooling habits, to poor sleep and fussiness, with mixed results in the scientific literature on the efficacy of probiotics for symptom resolution. Despite the growing interest in probiotics for consumer use, observed symptomatic relief is rarely documented. This study aims to evaluate observed symptomatic relief from at-home use of activated Bifidobacterium infantis EVC001 in infants. Consumer feedback was collected over a 2-year period via a 30-day post-purchase online survey of B. infantis EVC001 (Evivo®) customers. Outcome measures included observed changes in diaper rash, symptoms of colic, and sleep behaviours in infants fed B. infantis EVC001. A total of 1,621 respondents completed the survey. Before purchasing B. infantis EVC001, the majority of respondents visited the product website, researched infant probiotics online, or consulted with their doctor or other healthcare professional. Of the participants whose infants had ever experienced diaper rash, 72% (n=448) reported improvements, and 57% of those reported complete resolution of this problem. Of those who responded to questions about gassiness/fussiness, naptime sleep, and night-time sleep behaviours, 63% (n=984), 33% (n=520), and 52% (n=806) reported resolution or improvements, respectively. Although clinical data regarding probiotic use are often inconclusive for symptom resolution, home use of B. infantis EVC001 in infants improved diaper rash, gassiness/fussiness, and sleep quality within the first week of use in a significant number of respondents who engaged in a voluntary post-purchase survey. These outcomes may be a result of the unique genetic capacity of B. infantis EVC001 to colonise the infant gut highlighting the importance of strain selection in evaluating the effects of probiotic products.
-
Andersen, S.S., Michaelsen, K.F., Laursen, R.P. and Holm, L., 2018. Why parents are skeptical about using probiotics preventively for small children: a Danish qualitative study. BMC Complementary and Alternative Medicine 18: 336. https://doi.org/10.1186/s12906-018-2387-2
-
Berg, R.W., Milligan, M.C. and Sarbaugh, F.C., 1994. Association of skin wetness and pH with diaper dermatitis. Pediatric Dermatology 11: 18-20. https://doi.org/10.1111/j.1525-1470.1994.tb00066.x
-
Bridgman, S.L., Azad, M.B., Field, C.J., Letourneau, N., Johnston, D.W., Kaplan, B.J. and Kozyrskyj, A.L., 2014. Maternal perspectives on the use of probiotics in infants: a cross-sectional survey. BMC Complementary and Alternative Medicine 14: 366. https://doi.org/10.1186/1472-6882-14-366
-
Brown, E.M., Kenny, D.J. and Xavier, R.J., 2019. Gut microbiota regulation of T cells during inflammation and autoimmunity. Annual Review of Immunology 37: 599-624. https://doi.org/10.1146/annurev-immunol-042718-041841
-
Carr, A.N., DeWitt, T., Cork, M.J., Eichenfield, L.F., Fölster-Holst, R., Hohl, D., Lane, A.T., Paller, A., Pickering, L., Taieb, A., Cui, T.Y., Xu, Z.G., Wang, X., Brink, S., Niu, Y., Ogle, J., Odio, M. and Gibb, R.D., 2020. Diaper dermatitis prevalence and severity: global perspective on the impact of caregiver behavior. Pediatric Dermatology 37: 130-136. https://doi.org/10.1111/pde.14047
-
Casaburi, G. and Frese, S.A., 2018. Colonization of breastfed infants by Bifidobacterium longum subsp. infantis EVC001 reduces virulence gene abundance. Human Microbiome Journal 9: 7-10. https://doi.org/10.1016/j.humic.2018.05.001
-
Duar, R.M., Henrick, B.M., Casaburi, G. and Frese, S.A., 2020a. Integrating the ecosystem services framework to define dysbiosis of the breastfed infant gut: the role of B. infantis and human milk oligosaccharides. Frontiers in Nutrition 7: 33. https://doi.org/10.3389/fnut.2020.00033
-
Duar, R.M., Kyle, D. and Casaburi, G., 2020b. Colonization resistance in the infant gut: the role of B. infantis in reducing pH and preventing pathogen growth. High-Throughput 9: 7. https://doi.org/10.3390/ht9020007
-
Evrensel, A. and Ceylan, M.E., 2015. The gut-brain axis: the missing link in depression. Clinical Psychopharmacology and Neuroscience 13: 239-244. https://doi.org/10.9758/cpn.2015.13.3.239
-
Field, T., 2017. Infant sleep problems and interventions: a review. Infant Behavior and Development 47: 40-53. https://doi.org/10.1016/j.infbeh.2017.02.002
-
Frese, S.A., Hutton, A.A., Contreras, L.N., Shaw, C.A., Palumbo, M.C., Casaburi, G., Xu, G., Davis, J.C.C., Lebrilla, C.B., Henrick, B.M., Freeman, S.L., Barile, D., German, J.B., Mills, D.A., Smilowitz, J.T. and Underwood, M.A., 2017. Persistence of supplemented Bifidobacterium longum subsp. infantis EVC001 in breastfed infants. MSphere 2: e00501-17. https://doi.org/10.1128/msphere.00501-17
-
Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J.M., Topping, D.L., Suzuki, T., Taylor, T.D., Itoh, K., Kikuchi, J., Morita, H., Hattori, M. and Ohno, H., 2011. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469: 543-549. https://doi.org/10.1038/nature09646
-
Gordon, M., Biagioli, E., Sorrenti, M., Lingua, C., Moja, L., Banks, S.S.C., Ceratto, S. and Savino, F., 2018. Dietary modifications for infantile colic. Cochrane Database of Systematic Reviews 10: CD011029. https://doi.org/10.1002/14651858.CD011029.pub2
-
He, C., Shan, Y. and Song, W., 2015. Targeting gut microbiota as a possible therapy for diabetes. Nutrition Research 35: 361-367. https://doi.org/10.1016/j.nutres.2015.03.002
-
Henrick, B.M., Chew, S., Casaburi, G., Brown, H.K., Frese, S.A., Zhou, Y., Underwood, M.A. and Smilowitz, J.T., 2019. Colonization by B. infantis EVC001 modulates enteric inflammation in exclusively breastfed infants. Pediatric Research 86: 749-757. https://doi.org/10.1038/s41390-019-0533-2
-
Henrick, B.M., Hutton, A.A., Palumbo, M.C., Casaburi, G., Mitchell, R.D., Underwood, M.A., Smilowitz, J.T. and Frese, S.A., 2018. Elevated fecal pH indicates a profound change in the breastfed infant gut microbiome due to reduction of Bifidobacterium over the past century. MSphere 3: e00041-18. https://doi.org/10.1128/msphere.00041-18
-
Karav, S., Casaburi, G. and Frese, S.A., 2018. Reduced colonic mucin degradation in breastfed infants colonized by Bifidobacterium longum subsp. infantis EVC001. FEBS Open Bio 8: 1649-1657. https://doi.org/10.1002/2211-5463.12516
-
Lawley, T.D. and Walker, A.W., 2013. Intestinal colonization resistance. Immunology 138: 1-11. https://doi.org/10.1111/j.1365-2567.2012.03616.x
-
Nishida, A., Inoue, R., Inatomi, O., Bamba, S., Naito, Y. and Andoh, A., 2018. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clinical Journal of Gastroenterology 11: 1-10. https://doi.org/10.1007/s12328-017-0813-5
-
Reuter, A., Silfverdal, S., Lindblom, K. and Hjern, A., 2020. A systematic review of prevention and treatment of infant behavioural sleep problems. Acta Paediatrica 109: 1717-1732. https://doi.org/10.1111/apa.15182
-
Rhoads, J.M., Collins, J., Fatheree, N.Y., Hashmi, S.S., Taylor, C.M., Luo, M., Hoang, T.K., Gleason, W.A., Van Arsdall, M.R., Navarro, F.N. and Liu, Y., 2018. Infant colic represents gut inflammation and dysbiosis. Journal of Pediatrics 203: 55-61. https://doi.org/10.1016/j.jpeds.2018.07.042
-
Smilowitz, J.T., Lebrilla, C.B., Mills, D.A., German, J.B. and Freeman, S.L., 2014. Breast milk oligosaccharides: structure-function relationships in the neonate. Annual Review of Nutrition 34: 143-169. https://doi.org/10.1146/annurev-nutr-071813-105721
-
Suez, J., Zmora, N., Segal, E. and Elinav, E., 2019. The pros, cons, and many unknowns of probiotics. Nature Medicine 25: 716-729. https://doi.org/10.1038/s41591-019-0439-x
-
Tannock, G.W., Lee, P.S., Wong, K.H. and Lawley, B., 2016. Why don’t all infants have bifidobacteria in their stool? Frontiers in Microbiology 7: 834. https://doi.org/10.3389/fmicb.2016.00834
-
Torres-Fuentes, C., Schellekens, H., Dinan, T.G. and Cryan, J.F., 2017. The microbiota-gut-brain axis in obesity. The Lancet Gastroenterology and Hepatology 2: 747-756. https://doi.org/10.1016/S2468-1253(17)30147-4
-
Underwood, M.A., German, J.B., Lebrilla, C.B. and Mills, D.A., 2015. Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatric Research 77: 229-235. https://doi.org/10.1038/pr.2014.156
-
Wolke, D., Bilgin, A. and Samara, M., 2017. Systematic review and meta-analysis: fussing and crying durations and prevalence of colic in infants. Journal of Pediatrics 185: 55-61. https://doi.org/10.1016/j.jpeds.2017.02.020
-
Yassour, M., Vatanen, T., Siljander, H., Hämäläinen, A.M., Härkönen, T., Ryhänen, S.J., Franzosa, E.A., Vlamakis, H., Huttenhower, C., Gevers, D., Lander, E.S., Knip, M., the DIABIMMUNE Study Group and Xavier, R.J., 2016. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Science Translational Medicine 8: 343ra81. https://doi.org/10.1126/scitranslmed.aad0917
-
Zeevenhooven, J., Browne, P.D., L’Hoir, M.P., De Weerth, C. and Benninga, M.A., 2018. Infant colic: mechanisms and management. Nature Reviews Gastroenterology and Hepatology 15: 479-496. https://doi.org/10.1038/s41575-018-0008-7
Supplementary Materials
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 0 | 0 | 0 |
| Gesamttextansichten | 727 | 307 | 26 |
| PDF-Downloads | 832 | 318 | 19 |
Symptomatic relief from at-home use of activated Bifidobacterium infantis EVC001 probiotic in infants: results from a consumer survey on the effects on diaper rash, colic symptoms, and sleep
in Beneficial MicrobesSearch for other papers by S.M. Dimitratos in
Current site
Google Scholar
PubMed
Search for other papers by H. Brown in
Current site
Google Scholar
PubMed
Search for other papers by T. Shafizadeh in
Current site
Google Scholar
PubMed
Search for other papers by S. Kazi in
Current site
Google Scholar
PubMed
Calabasas Pediatrics Wellness Center, Calabasas, CA 91302, USA.
Search for other papers by T. Altmann in
Current site
Google Scholar
PubMed
Search for other papers by B. Ostrer in
Current site
Google Scholar
PubMed
The gut microbiome during infancy is directly involved in the digestion of human milk, development of the immune system, and long-term health outcomes. Gut dysbiosis in early life has been linked to multiple short-term ailments, from diaper dermatitis and poor stooling habits, to poor sleep and fussiness, with mixed results in the scientific literature on the efficacy of probiotics for symptom resolution. Despite the growing interest in probiotics for consumer use, observed symptomatic relief is rarely documented. This study aims to evaluate observed symptomatic relief from at-home use of activated Bifidobacterium infantis EVC001 in infants. Consumer feedback was collected over a 2-year period via a 30-day post-purchase online survey of B. infantis EVC001 (Evivo®) customers. Outcome measures included observed changes in diaper rash, symptoms of colic, and sleep behaviours in infants fed B. infantis EVC001. A total of 1,621 respondents completed the survey. Before purchasing B. infantis EVC001, the majority of respondents visited the product website, researched infant probiotics online, or consulted with their doctor or other healthcare professional. Of the participants whose infants had ever experienced diaper rash, 72% (n=448) reported improvements, and 57% of those reported complete resolution of this problem. Of those who responded to questions about gassiness/fussiness, naptime sleep, and night-time sleep behaviours, 63% (n=984), 33% (n=520), and 52% (n=806) reported resolution or improvements, respectively. Although clinical data regarding probiotic use are often inconclusive for symptom resolution, home use of B. infantis EVC001 in infants improved diaper rash, gassiness/fussiness, and sleep quality within the first week of use in a significant number of respondents who engaged in a voluntary post-purchase survey. These outcomes may be a result of the unique genetic capacity of B. infantis EVC001 to colonise the infant gut highlighting the importance of strain selection in evaluating the effects of probiotic products.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 0 | 0 | 0 |
| Gesamttextansichten | 727 | 307 | 26 |
| PDF-Downloads | 832 | 318 | 19 |
